Testing effectiveness (Phase 2)Study completedNCT00030394
What this trial is testing
Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
Who this might be right for
Childhood Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 PositiveChronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI) 64